This compound is a tert-butyl carbamate derivative featuring a fluoropropyl-substituted azetidine ring. It is used as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2222845-47-6
(R)-1-(1H-indazol-4-yl)propan-2-amine hydrochloride
pharmaceutical intermediate
1-(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Afatinib Impurity)
pharmaceutical reference impurity
N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide
Pharmaceutical intermediate for Afatinib impurities
(S)-N1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-N2,N2-DIMETHYLOXALAMIDE
pharmaceutical intermediate
Azetidine hydrochloride
Research reagent
Azacyclobutane
pharmaceutical intermediate
(3-Fluoroazetidin-3-yl)methanol hydrochloride
pharmaceutical intermediate
3-Hydroxyazetidine hydrochloride
pharmaceutical intermediate
tert-butyl N-[1-(3-fluoropropyl)azetidin-3-yl]carbamate
DMVHTPKYWKOOPU-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CN(C1)CCCF
—